Literature DB >> 21172912

Statistical analysis of the cancer cell's molecular entropy using high-throughput data.

Wessel N van Wieringen1, Aad W van der Vaart.   

Abstract

MOTIVATION: As cancer progresses, DNA copy number aberrations accumulate and the genomic entropy (chromosomal disorganization) increases. For this surge to have any oncogenetic effect, it should (to some extent) be reflected at other molecular levels of the cancer cell, in particular that of the transcriptome. Such a coincidence of cancer progression and the propagation of an entropy increase through the molecular levels of the cancer cell would enhance the understanding of cancer evolution.
RESULTS: A statistical argument reveals that (under some assumptions) an entropy increase in one random variable (DNA copy number) leads to an entropy increase in another (gene expression). Statistical methodology is provided to investigate the relation between the genomic and transcriptomic entropy using high-throughput data. Analyses of multiple high-throughput datasets using this methodology show a close, concordant relation among the genomic and transcriptomic entropy. Hence, as cancer evolves, and the genomic entropy increases, the transcriptomic entropy is also expected to surge.

Entities:  

Mesh:

Year:  2010        PMID: 21172912     DOI: 10.1093/bioinformatics/btq704

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  18 in total

Review 1.  Statistical mechanics meets single-cell biology.

Authors:  Andrew E Teschendorff; Andrew P Feinberg
Journal:  Nat Rev Genet       Date:  2021-04-19       Impact factor: 53.242

2.  Cancer develops, progresses and responds to therapies through restricted perturbation of the protein-protein interaction network.

Authors:  Jordi Serra-Musach; Helena Aguilar; Francesco Iorio; Francesc Comellas; Antoni Berenguer; Joan Brunet; Julio Saez-Rodriguez; Miguel Angel Pujana
Journal:  Integr Biol (Camb)       Date:  2012-07-18       Impact factor: 2.192

3.  Matching of array CGH and gene expression microarray features for the purpose of integrative genomic analyses.

Authors:  Wessel N van Wieringen; Kristian Unger; Gwenaël G R Leday; Oscar Krijgsman; Renée X de Menezes; Bauke Ylstra; Mark A van de Wiel
Journal:  BMC Bioinformatics       Date:  2012-05-04       Impact factor: 3.169

4.  Integrative subtype discovery in glioblastoma using iCluster.

Authors:  Ronglai Shen; Qianxing Mo; Nikolaus Schultz; Venkatraman E Seshan; Adam B Olshen; Jason Huse; Marc Ladanyi; Chris Sander
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

5.  Semi-supervised adaptive-height snipping of the hierarchical clustering tree.

Authors:  Askar Obulkasim; Gerrit A Meijer; Mark A van de Wiel
Journal:  BMC Bioinformatics       Date:  2015-01-16       Impact factor: 3.169

6.  FastGCN: a GPU accelerated tool for fast gene co-expression networks.

Authors:  Meimei Liang; Futao Zhang; Gulei Jin; Jun Zhu
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

7.  Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.

Authors:  Christopher R S Banerji; Simone Severini; Carlos Caldas; Andrew E Teschendorff
Journal:  PLoS Comput Biol       Date:  2015-03-20       Impact factor: 4.475

8.  Differential network entropy reveals cancer system hallmarks.

Authors:  James West; Ginestra Bianconi; Simone Severini; Andrew E Teschendorff
Journal:  Sci Rep       Date:  2012-11-13       Impact factor: 4.379

9.  Isolation of circulating tumor cells by dielectrophoresis.

Authors:  Peter R C Gascoyne; Sangjo Shim
Journal:  Cancers (Basel)       Date:  2014-03-12       Impact factor: 6.639

Review 10.  Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence".

Authors:  M Tarabichi; A Antoniou; M Saiselet; J M Pita; G Andry; J E Dumont; V Detours; C Maenhaut
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.